The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
Abstract
:1. Introduction
2. Catheter-Related Candidemia
3. Candida Biofilm
3.1. Composition
3.2. Formation
3.3. Genetic Mechanisms of Biofilm Formation
3.4. Measurement of Biofilm Formation
3.5. Clinical Aspects of Candida Biofilm
4. Antifungal Activity against Candida Biofilm
4.1. In Vitro Activity of Antifungals to Eradicate Candida Biofilm
4.2. In Vivo Activity of Antifungals Administered to Eradicate Candida Biofilms
4.3. Clinical Studies on the Management of Candida Biofilm in CRC
4.3.1. Therapeutic Approaches
4.3.2. Novel Preventive Approaches
Candida Biofilm |
|
|
|
|
Activity of antifungals against Candida biofilm |
|
|
|
|
|
Clinical aspects of Candida biofilms |
|
|
|
|
|
5. Conclusions
Acknowledgements
Author Contributions
Conflicts of Interest
References
- Crump, J.A.; Collignon, P.J. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19, 1–8. [Google Scholar] [PubMed]
- Weinberger, M.; Leibovici, L.; Perez, S.; Samra, Z.; Ostfeld, I.; Levi, I.; Bash, E.; Turner, D.; Goldschmied-Reouven, A.; Regev-Yochay, G.; et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect. 2005, 61, 146–154. [Google Scholar] [PubMed]
- Velasco, E.; Bigni, R. A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27, 1071–1078. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, A.V.; Prado, C.G.; Carvalho, R.R.; Dias, K.S.; Dias, A.L. Candida albicans and non-C. albicans Candida species: Comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia 2012, 175, 265–272. [Google Scholar] [CrossRef]
- Goldmann, D.A.; Pier, G.B. Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev. 1993, 6, 176–192. [Google Scholar] [PubMed]
- Donlan, R.M. Biofilm formation: A clinically relevant microbiological process. Clin. Infect. Dis. 2001, 33, 1387–1392. [Google Scholar] [CrossRef] [PubMed]
- Kumamoto, C.A. Candida biofilms. Curr. Opin. Microbiol. 2002, 5, 608–611. [Google Scholar] [CrossRef] [PubMed]
- Ramage, G.; Saville, S.P.; Thomas, D.P.; Lopez-Ribot, J.L. Candida biofilms: An update. Eukaryot. Cell 2005, 4, 633–638. [Google Scholar] [CrossRef] [PubMed]
- Silva, S.; Negri, M.; Henriques, M.; Oliveira, R.; Williams, D.W.; Azeredo, J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011, 19, 241–247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Silva, S.; Henriques, M.; Martins, A.; Oliveira, R.; Williams, D.; Azeredo, J. Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition. Med. Mycol. 2009, 47, 681–689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marcos-Zambrano, L.J.; Escribano, P.; Bouza, E.; Guinea, J. Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: Comparison of biomass production and metabolic activity and development of cut-off points. Int. J. Med. Microbiol. 2014, 304, 1192–1198. [Google Scholar] [CrossRef] [PubMed]
- Harding, M.W.; Marques, L.L.; Howard, R.J.; Olson, M.E. Can filamentous fungi form biofilms? Trends Microbiol. 2009, 17, 475–480. [Google Scholar] [CrossRef] [PubMed]
- Tortorano, A.M.; Prigitano, A.; Lazzarini, C.; Passera, M.; Deiana, M.L.; Cavinato, S.; de Luca, C.; Grancini, A.; Lo Cascio, G.; Ossi, C.; et al. A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection 2013, 41, 655–662. [Google Scholar] [CrossRef] [PubMed]
- Wey, S.B.; Mori, M.; Pfaller, M.A.; Woolson, R.F.; Wenzel, R.P. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 1988, 148, 642–645. [Google Scholar] [CrossRef]
- Ben-Ami, R.; Weinberger, M.; Orni-Wasserlauff, R.; Schwartz, D.; Itzhaki, A.; Lazarovitch, T.; Bash, E.; Aharoni, Y.; Moroz, I.; Giladi, M. Time to blood culture positivity as a marker for catheter-related candidemia. J. Clin. Microbiol. 2008, 46, 2222–2226. [Google Scholar] [CrossRef] [PubMed]
- Fernandez-Cruz, A.; Martin-Rabadan, P.; Suarez-Salas, M.; Rojas-Wettig, L.; Perez, M.J.; Guinea, J.; Guembe, M.; Peláez, T.; Sánchez-Carrillo, C.; Bouza, E. Is it feasible to diagnose catheter-related candidemia without catheter withdrawal? Med. Mycol. 2014, 52, 491–497. [Google Scholar] [CrossRef]
- Bouza, E.; Alcala, L.; Munoz, P.; Martin-Rabadan, P.; Guembe, M.; Rodriguez-Creixems, M. Can microbiologists help to assess catheter involvement in candidaemic patients before removal? Clin. Microbiol. Infect. 2013, 19, E129–E135. [Google Scholar] [CrossRef] [PubMed]
- Donlan, R.M.; Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15, 167–193. [Google Scholar] [CrossRef] [PubMed]
- Donlan, R.M. Biofilms and device-associated infections. Emerg. Infect. Dis. 2001, 7, 277–281. [Google Scholar] [CrossRef] [PubMed]
- Ramage, G.; Williams, C. The clinical importance of fungal biofilms. Adv. Appl. Microbiol. 2013, 84, 27–83. [Google Scholar] [PubMed]
- Ramage, G.; Mowat, E.; Jones, B.; Williams, C.; Lopez-Ribot, J. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 2009, 35, 340–355. [Google Scholar] [CrossRef] [PubMed]
- Ramage, G.; Vandewalle, K.; Wickes, B.L.; Lopez-Ribot, J.L. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 2001, 18, 163–170. [Google Scholar] [PubMed]
- Nett, J.; Andes, D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 2006, 9, 340–345. [Google Scholar] [CrossRef] [PubMed]
- Blankenship, J.R.; Mitchell, A.P. How to build a biofilm: A fungal perspective. Curr. Opin. Microbiol. 2006, 9, 588–594. [Google Scholar] [CrossRef] [PubMed]
- Baillie, G.S.; Douglas, L.J. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 1999, 48, 671–679. [Google Scholar] [CrossRef] [PubMed]
- Hornby, J.M.; Jensen, E.C.; Lisec, A.D.; Tasto, J.J.; Jahnke, B.; Shoemaker, R.; Dussault, P.; Nickerson, K.W. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 2001, 67, 2982–2992. [Google Scholar] [CrossRef] [PubMed]
- Garcia, M.C.; Lee, J.T.; Ramsook, C.B.; Alsteens, D.; Dufrene, Y.F.; Lipke, P.N. A role for amyloid in cell aggregation and biofilm formation. PLoS ONE 2011, 6, e17632. [Google Scholar] [CrossRef] [PubMed]
- Deveau, A.; Hogan, D.A. Linking quorum sensing regulation and biofilm formation by Candida albicans. Methods Mol. Biol. 2011, 692, 219–233. [Google Scholar]
- Fanning, S.; Mitchell, A.P. Fungal biofilms. PLoS Pathog. 2012, 8, e1002585. [Google Scholar] [CrossRef]
- Chandra, J.; Kuhn, D.M.; Mukherjee, P.K.; Hoyer, L.L.; McCormick, T.; Ghannoum, M.A. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J. Bacteriol. 2001, 183, 5385–5394. [Google Scholar] [CrossRef] [PubMed]
- Nett, J.E.; Sanchez, H.; Cain, M.T.; Ross, K.M.; Andes, D.R. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell. 2011, 10, 1660–1669. [Google Scholar] [CrossRef] [PubMed]
- Coenye, T.; Nelis, H.J. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 2010, 83, 89–105. [Google Scholar] [CrossRef] [PubMed]
- Hawser, S.P.; Douglas, L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 1994, 62, 915–921. [Google Scholar] [PubMed]
- Uppuluri, P.; Lopez-Ribot, J.L. An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence 2010, 1, 483–487. [Google Scholar] [CrossRef] [PubMed]
- Lebeaux, D.K.I.; Decante, B.; Ghigo, J.; Beloin, C.; Plessis-Robinson, L. Modelling of controlled biofilm infection using rats with totally implantable port access intravenous catheter. In Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, 7–10 May 2011. Abstract No. O187.
- Nett, J.E.; Marchillo, K.; Andes, D.R. Modeling of fungal biofilms using a rat central vein catheter. Methods Mol. Biol. 2012, 845, 547–556. [Google Scholar] [PubMed]
- Chandra, J.; Long, L.; Ghannoum, M.A.; Mukherjee, P.K. A rabbit model for evaluation of catheter-associated fungal biofilms. Virulence 2011, 2, 466–474. [Google Scholar] [CrossRef] [PubMed]
- Ricicova, M.; Kucharikova, S.; Tournu, H.; Hendrix, J.; Bujdakova, H.; van Eldere, J.; Lagrou, K.; van Dijck, P. Candida albicans biofilm formation in a new in vivo rat model. Microbiology 2010, 156, 909–919. [Google Scholar] [CrossRef] [PubMed]
- O’Toole, G.A. Microtiter dish biofilm formation assay. J. Vis. Exp. 2011. [Google Scholar] [CrossRef]
- Stepanovic, S.; Cirkovic, I.; Ranin, L.; Svabic-Vlahovic, M. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett. Appl. Microbiol. 2004, 38, 428–432. [Google Scholar] [CrossRef] [PubMed]
- Taff, H.T.; Nett, J.E.; Andes, D.R. Comparative analysis of Candida biofilm quantitation assays. Med. Mycol. 2011, 50, 214–218. [Google Scholar] [CrossRef] [PubMed]
- Kuhn, D.M.; Balkis, M.; Chandra, J.; Mukherjee, P.K.; Ghannoum, M.A. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 2003, 41, 506–508. [Google Scholar] [CrossRef] [PubMed]
- Hawser, S.P.; Norris, H.; Jessup, C.J.; Ghannoum, M.A. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J. Clin. Microbiol. 1998, 36, 1450–1452. [Google Scholar] [PubMed]
- Levitz, S.M.; Diamond, R.D. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 1985, 152, 938–945. [Google Scholar] [CrossRef] [PubMed]
- Pierce, C.G.; Uppuluri, P.; Tristan, A.R.; Wormley, F.L., Jr.; Mowat, E.; Ramage, G.; Lopez-Ribot, J.L. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 2008, 3, 1494–1500. [Google Scholar] [CrossRef] [PubMed]
- Ramage, G.; Vande Walle, K.; Wickes, B.L.; Lopez-Ribot, J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 2001, 45, 2475–2479. [Google Scholar] [CrossRef] [PubMed]
- Kumar, C.P.; Menon, T. Biofilm production by clinical isolates of Candida species. Med. Mycol. 2006, 44, 99–101. [Google Scholar] [CrossRef] [PubMed]
- Guembe, M.; Guinea, J.; Marcos-Zambrano, L.; Fernandez-Cruz, A.; Pelaez, T.; Munoz, P.; Bouza, E. Is biofilm production a predictor of catheter-related candidemia? Med. Mycol. 2014, 52, 407–410. [Google Scholar] [CrossRef] [PubMed]
- Ruiz, L.S.; Khouri, S.; Hahn, R.C.; da Silva, E.G.; de Oliveira, V.K.; Gandra, R.F.; Paula, C.R. Candidemia by species of the Candida parapsilosis complex in children’s hospital: Prevalence, biofilm production and antifungal susceptibility. Mycopathologia 2013, 175, 231–239. [Google Scholar] [CrossRef] [PubMed]
- Douglas, L.J. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 2002, 19, 139–143. [Google Scholar] [PubMed]
- Kojic, E.M.; Darouiche, R.O. Candida infections of medical devices. Clin. Microbiol. Rev. 2004, 17, 255–267. [Google Scholar] [CrossRef] [PubMed]
- Ramage, G.; Martinez, J.P.; Lopez-Ribot, J.L. Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res. 2006, 6, 979–986. [Google Scholar] [CrossRef] [PubMed]
- Swindell, K.; Lattif, A.A.; Chandra, J.; Mukherjee, P.K.; Ghannoum, M.A. Parenteral lipid emulsion induces germination of Candida albicans and increases biofilm formation on medical catheter surfaces. J. Infect. Dis. 2009, 200, 473–480. [Google Scholar] [CrossRef] [PubMed]
- Opilla, M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am. J. Infect. Control 2008, 36, S173.e5–S173.e8. [Google Scholar] [CrossRef] [PubMed]
- Melo, A.S.; Bizerra, F.C.; Freymuller, E.; Arthington-Skaggs, B.A.; Colombo, A.L. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med. Mycol. 2011, 49, 253–262. [Google Scholar] [CrossRef] [PubMed]
- Lewis, R.E.; Kontoyiannis, D.P.; Darouiche, R.O.; Raad, I.I.; Prince, R.A. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob. Agents Chemother. 2002, 46, 3499–3505. [Google Scholar] [CrossRef] [PubMed]
- Uppuluri, P.; Srinivasan, A.; Ramasubramanian, A.; Lopez-Ribot, J.L. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob. Agents Chemother. 2011, 55, 3591–3593. [Google Scholar] [CrossRef] [PubMed]
- Shuford, J.A.; Piper, K.E.; Steckelberg, J.M.; Patel, R. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. 2007, 57, 277–281. [Google Scholar] [CrossRef] [PubMed]
- Shi, W.; Chen, Z.; Chen, X.; Cao, L.; Liu, P.; Sun, S. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: An in vitro interaction of antifungal and antibacterial agents. FEMS Yeast Res. 2010, 10, 885–893. [Google Scholar] [CrossRef] [PubMed]
- Kuhn, D.M.; George, T.; Chandra, J.; Mukherjee, P.K.; Ghannoum, M.A. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 2002, 46, 1773–1780. [Google Scholar] [CrossRef] [PubMed]
- Bachmann, S.P.; Ramage, G.; VandeWalle, K.; Patterson, T.F.; Wickes, B.L.; Lopez-Ribot, J.L. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob. Agents Chemother. 2003, 47, 3657–3659. [Google Scholar] [CrossRef] [PubMed]
- Tobudic, S.; Kratzer, C.; Lassnigg, A.; Graninger, W.; Presterl, E. In vitro activity of antifungal combinations against Candida albicans biofilms. J. Antimicrob. Chemother. 2010, 65, 271–274. [Google Scholar] [CrossRef] [PubMed]
- Simitsopoulou, M.; Peshkova, P.; Tasina, E.; Katragkou, A.; Kyrpitzi, D.; Velegraki, A.; Walsh, T.J.; Roilides, E. Speciespecific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: Characterization of less common bloodstream isolates. Antimicrob. Agents Chemother. 2013, 57, 2562–2570. [Google Scholar] [CrossRef] [PubMed]
- Guembe, M.; Guinea, J.; Marcos-Zambrano, L.J.; Fernandez-Cruz, A.; Pelaez, T.; Munoz, P.; Bouza, E. Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms. Antimicrob. Agents Chemother. 2014, 58, 5581–5584. [Google Scholar] [CrossRef] [PubMed]
- Choi, H.W.; Shin, J.H.; Jung, S.I.; Park, K.H.; Cho, D.; Kee, S.J.; Shin, M.G.; Suh, S.P.; Ryang, D.W. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob. Agents Chemother. 2007, 51, 1520–1523. [Google Scholar] [CrossRef]
- Bachmann, S.P.; VandeWalle, K.; Ramage, G.; Patterson, T.F.; Wickes, B.L.; Graybill, J.R.; López-Ribot, J.L. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 2002, 46, 3591–3596. [Google Scholar] [CrossRef] [PubMed]
- Rosato, A.; Piarulli, M.; Schiavone, B.P.; Catalano, A.; Carocci, A.; Carrieri, A.; Carone, A.; Caggiano, G.; Franchini, C.; Corbo, F.; et al. In vitro effectiveness of anidulafungin against Candida sp. biofilms. J. Antibiot. (Tokyo) 2013, 66, 701–704. [Google Scholar] [CrossRef]
- Jacobson, M.J.; Piper, K.E.; Nguyen, G.; Steckelberg, J.M.; Patel, R. In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 2008, 52, 2242–2243. [Google Scholar] [CrossRef] [PubMed]
- Valentin, A.; Canton, E.; Peman, J.; Quindos, G. In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms. Rev. Iberoam. Micol. 2007, 24, 272–277. [Google Scholar] [CrossRef] [PubMed]
- Fiori, B.; Posteraro, B.; Torelli, R.; Tumbarello, M.; Perlin, D.S.; Fadda, G.; Sanguinetti, M. In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species. Antimicrob. Agents Chemother. 2011, 55, 3031–3035. [Google Scholar] [CrossRef] [PubMed]
- Nweze, E.I.; Ghannoum, A.; Chandra, J.; Ghannoum, M.A.; Mukherjee, P.K. Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms. J. Antimicrob. Chemother. 2012, 67, 149–153. [Google Scholar] [CrossRef] [PubMed]
- Bernhardt, H.; Knoke, M.; Bernhardt, J. Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation. Mycoses 2011, 54, e821–e827. [Google Scholar] [CrossRef]
- Jacobson, M.J.; Steckelberg, K.E.; Piper, K.E.; Steckelberg, J.M.; Patel, R. In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrob. Agents Chemother. 2009, 53, 2638–2639. [Google Scholar] [CrossRef] [PubMed]
- Miceli, M.H.; Bernardo, S.M.; Lee, S.A. In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms. Int. J. Antimicrob. Agents. 2009, 34, 500–502. [Google Scholar] [CrossRef]
- Ku, T.S.; Bernardo, S.M.; Lee, S.A. In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms. J. Med. Microbiol. 2011, 60, 1708–1170. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, J.A.; Carr, J.H.; Starling, C.E.; de Resende, M.A.; Donlan, R.M. Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob. Agents Chemother. 2009, 53, 4377–4384. [Google Scholar]
- Peman, J.; Canton, E.; Valentin, A. Activity of anidulafungin against Candida biofilms. Rev. Iberoam Micol. 2008, 25, 124–128. [Google Scholar] [CrossRef] [PubMed]
- Cocuaud, C.; Rodier, M.H.; Daniault, G.; Imbert, C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J. Antimicrob. Chemother. 2005, 56, 507–512. [Google Scholar] [CrossRef]
- Kaneko, Y.; Miyagawa, S.; Takeda, O.; Hakariya, M.; Matsumoto, S.; Ohno, H.; Miyazaki, Y. Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole. Antimicrob. Agents Chemother. 2013, 57, 2226–2230. [Google Scholar] [CrossRef] [PubMed]
- Seidler, M.; Salvenmoser, S.; Muller, F.M. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int. J. Antimicrob. Agents 2006, 28, 568–573. [Google Scholar] [CrossRef] [PubMed]
- Toulet, D.; Debarre, C.; Imbert, C. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials? J. Antimicrob. Chemother. 2011, 67, 430–432. [Google Scholar] [CrossRef] [PubMed]
- Oncu, S. In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species. J. Infect. Chemother. 2011, 17, 634–639. [Google Scholar] [CrossRef] [PubMed]
- Cateau, E.; Rodier, M.H.; Imbert, C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J. Antimicrob. Chemother. 2008, 62, 153–155. [Google Scholar] [CrossRef] [PubMed]
- Cateau, E.; Berjeaud, J.M.; Imbert, C. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone. Int. J. Antimicrob. Agents. 2011, 37, 380–384. [Google Scholar] [CrossRef] [PubMed]
- Ko, K.S.; Lee, J.Y.; Song, J.H.; Peck, K.R. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. J. Korean Med. Sci. 2010, 25, 1722–1726. [Google Scholar] [CrossRef] [PubMed]
- Pires, R.H.; Montanari, L.B.; Martins, C.H.; Zaia, J.E.; Almeida, A.M.; Matsumoto, M.T.; Mendes-Gianinni, M.J.S. Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis. Mycopathologia 2011, 172, 453–464. [Google Scholar] [CrossRef] [PubMed]
- Rukayadi, Y.; Han, S.; Yong, D.; Hwang, J.K. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. Med. Mycol. 2011, 49, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Percival, S.L.; Kite, P.; Eastwood, K.; Murga, R.; Carr, J.; Arduino, M.J.; Donlan, R.M. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect. Control Hosp. Epidemiol. 2005, 26, 515–519. [Google Scholar] [CrossRef] [PubMed]
- Rane, H.S.; Bernardo, S.M.; Walraven, C.J.; Lee, S.A. In vitro analyses of ethanol activity against Candida albicans biofilms. Antimicrob. Agents Chemother. 2013, 56, 4487–4479. [Google Scholar] [CrossRef]
- Raad, I.; Rosenblatt, J.; Reitzel, R.; Jiang, Y.; Dvorak, T.; Hachem, R. Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob. Agents Chemother. 2013, 57, 586–588. [Google Scholar] [CrossRef] [PubMed]
- Raad, I.; Hanna, H.; Dvorak, T.; Chaiban, G.; Hachem, R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob. Agents Chemother. 2007, 51, 78–83. [Google Scholar] [CrossRef] [PubMed]
- Rosenblatt, J.; Reitzel, R.; Dvorak, T.; Jiang, Y.; Hachem, R.Y.; Raad, I.I. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob. Agents Chemother. 2013, 57, 3555–3560. [Google Scholar] [CrossRef] [PubMed]
- Mukherjee, P.K.; Long, L.; Kim, H.G.; Ghannoum, M.A. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms. Int. J. Antimicrob. Agents 2009, 33, 149–153. [Google Scholar] [CrossRef] [PubMed]
- Schinabeck, M.K.; Long, L.A.; Hossain, M.A.; Chandra, J.; Mukherjee, P.K.; Mohamed, S.; Ghannoum, M.A. Rabbit model of Candida albicans biofilm infection: Liposomal amphotericin B antifungal lock therapy. Antimicrob. Agents Chemother. 2004, 48, 1727–1732. [Google Scholar] [CrossRef] [PubMed]
- Shuford, J.A.; Rouse, M.S.; Piper, K.E.; Steckelberg, J.M.; Patel, R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J. Infect. Dis. 2006, 194, 710–713. [Google Scholar] [CrossRef] [PubMed]
- Lazzell, A.L.; Chaturvedi, A.K.; Pierce, C.G.; Prasad, D.; Uppuluri, P.; Lopez-Ribot, J.L. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J. Antimicrob. Chemother. 2009, 64, 567–570. [Google Scholar] [CrossRef] [PubMed]
- Kucharikova, S.; Sharma, N.; Spriet, I.; Maertens, J.; van Dijck, P.; Lagrou, K. Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Antimicrob. Agents Chemother. 2013, 57, 2365–2368. [Google Scholar] [CrossRef] [PubMed]
- Kucharikova, S.; Tournu, H.; Holtappels, M.; van Dijck, P.; Lagrou, K. In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis. Antimicrob. Agents Chemother. 2010, 4, 4474–4475. [Google Scholar] [CrossRef]
- Pappas, P.G.; Kauffman, C.A.; Andes, D.; Benjamin, D.K., Jr.; Calandra, T.F.; Edwards, J.E., Jr.; Filler, S.G.; Fisher, J.F.; Kullberg, B.J.; Ostrosky-Zeichner, L.; et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48, 503–535. [Google Scholar] [CrossRef] [PubMed]
- Samore, M.H.; Burke, J.P. Infections of long intravenous lines: New developments and controversies. Curr. Clin. Top. Infect. Dis. 2000, 20, 256–270. [Google Scholar] [PubMed]
- Nucci, M.; Anaissie, E.; Betts, R.F.; Dupont, B.F.; Wu, C.; Buell, D.N.; Kovanda, L.; Lortholary, O. Early removal of central venous catheter in patients with candidemia does not improve outcome: Analysis of 842 patients from 2 randomized clinical trials. Clin. Infect. Dis. 2010, 51, 295–303. [Google Scholar] [CrossRef] [PubMed]
- Brass, E.P.; Edwards, J.E. Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin. Infect. Dis. 2010, 51, 304–306. [Google Scholar] [CrossRef] [PubMed]
- Koh, G.C.; Luong, M.L. Early removal of central venous catheters and outcomes from candidemia. Clin. Infect. Dis. 2010, 51, 1347. [Google Scholar] [CrossRef] [PubMed]
- Garnacho-Montero, J.; Diaz-Martin, A.; Garcia-Cabrera, E.; Ruiz Perez de Pipaon, M.; Hernandez-Caballero, C.; Lepe-Jimenez, J.A. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections. J. Antimicrob. Chemother. 2013, 68, 206–213. [Google Scholar] [CrossRef] [PubMed]
- Tumbarello, M.; Fiori, B.; Trecarichi, E.M.; Posteraro, P.; Losito, A.R.; de Luca, A.; Sanguinetti, M.; Fadda, G.; Cauda, R.; Posteraro, B. Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS ONE 2013, 7, e33705. [Google Scholar] [CrossRef]
- Rodriguez, D.; Park, B.J.; Almirante, B.; Cuenca-Estrella, M.; Planes, A.M.; Mensa, J.; Gimenez, M.; Saballs, P.; Fridkin, S.K.; Rodriguez-Tudela, J.L.; et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin. Microbiol. Infect. 2007, 13, 788–793. [Google Scholar] [CrossRef] [PubMed]
- Raad, I.I.; Fang, X.; Keutgen, X.M.; Jiang, Y.; Sherertz, R.; Hachem, R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr. Opin. Infect. Dis. 2008, 21, 385–392. [Google Scholar] [CrossRef] [PubMed]
- Walraven, C.J.; Lee, S.A. Antifungal lock therapy. Antimicrob. Agents Chemother. 2013, 57, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Cobrado, L.; Silva-Dias, A.; Azevedo, M.M.; Pina-Vaz, C.; Rodrigues, A.G. In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections. J. Antimicrob. Chemother. 2013, 68, 126–130. [Google Scholar] [CrossRef] [PubMed]
- Raad, I.; Mohamed, J.A.; Reitzel, R.A.; Jiang, Y.; Raad, S.; al Shuaibi, M.; Chaftari, A.M.; Hachem, R.Y. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob. Agents Chemother. 2011, 56, 935–941. [Google Scholar] [CrossRef] [PubMed]
- Maki, D.G. In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clin. Infect. Dis. 2010, 50, 1580–1587. [Google Scholar] [CrossRef] [PubMed]
- Khare, M.D.; Bukhari, S.S.; Swann, A.; Spiers, P.; McLaren, I.; Myers, J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. J. Infect. 2007, 54, 146–150. [Google Scholar] [CrossRef] [PubMed]
- Martinez, L.R.; Mihu, M.R.; Tar, M.; Cordero, R.J.; Han, G.; Friedman, A.J.; Friedman, J.M.; Nosanchuk, J.D. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J. Infect. Dis. 2012, 201, 1436–1440. [Google Scholar] [CrossRef]
- Mermel, L.A.; Allon, M.; Bouza, E.; Craven, D.E.; Flynn, P.; O’Grady, N.P.; Raad, I.I.; Rijnders, B.J.; Sherertz, R.J.; Warren, D.K. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 49, 1–45. [Google Scholar] [CrossRef] [PubMed]
- Pieroni, K.P.; Nespor, C.; Poole, R.L.; Kerner, J.A., Jr.; Berquist, W.E. Echinocandin and ethanol lock therapy treatment of fungal catheter infections. Pediatr. Infect. Dis. J. 2013, 32, 289–291. [Google Scholar] [PubMed]
- Carratala, J. The antibiotic-lock technique for therapy of “highly needed” infected catheters. Clin. Microbiol. Infect. 2002, 8, 282–289. [Google Scholar] [CrossRef] [PubMed]
- Messing, B.; Peitra-Cohen, S.; Debure, A.; Beliah, M.; Bernier, J.J. Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J. Parenter Enteral Nutr. 1988, 12, 185–189. [Google Scholar] [CrossRef] [PubMed]
- Benoit, J.L.; Carandang, G.; Sitrin, M.; Arnow, P. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin. Infect. Dis. 1997, 24, 743–744. [Google Scholar] [CrossRef] [PubMed]
- Krzywda, E.A.; Andris, D.A.; Edmiston, C.E., Jr.; Quebbeman, E.J. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control Hosp. Epidemiol. 1995, 16, 596–598. [Google Scholar] [CrossRef] [PubMed]
- Ozdemir, H.; Karbuz, A.; Ciftci, E.; Dincaslan, H.U.; Ince, E.; Aysev, D.; Yavuz, G.; Doğru, U. Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy. Mycoses 2011, 54, e647–e649. [Google Scholar] [CrossRef] [PubMed]
- Arnow, P.M.; Kushner, R. Malassezia furfur catheter infection cured with antibiotic lock therapy. Am. J. Med. 1991, 90, 128–130. [Google Scholar] [CrossRef] [PubMed]
- Johnson, D.C.; Johnson, F.L.; Goldman, S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr. Infect. Dis. J. 1994, 13, 930–931. [Google Scholar] [CrossRef] [PubMed]
- Viale, P.; Petrosillo, N.; Signorini, L.; Puoti, M.; Carosi, G. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin. Infect. Dis. 2001, 33, 1947–1978. [Google Scholar] [CrossRef] [PubMed]
- Castagnola, E.; Marazzi, M.G.; Tacchella, A.; Giacchino, R. Broviac catheter-related candidemia. Pediatr. Infect. Dis. J. 2005, 24, 747. [Google Scholar] [CrossRef] [PubMed]
- Angel-Moreno, A.; Boronat, M.; Bolanos, M.; Carrillo, A.; Gonzalez, S.; Perez Arellano, J.L. Candida glabrata fungemia cured by antibiotic-lock therapy: Case report and short review. J. Infect. 2005, 51, e85–e87. [Google Scholar] [CrossRef] [PubMed]
- Wu, C.Y.; Lee, P.I. Antibiotic-lock therapy and erythromycin for treatment of catheter-related Candida parapsilosis and Staphylococcus aureus infections. J. Antimicrob. Chemother. 2007, 60, 706–707. [Google Scholar] [CrossRef] [PubMed]
- Buckler, B.S.; Sams, R.N.; Goei, V.L.; Krishnan, K.R.; Bemis, M.J.; Parker, D.P.; Murray, D.L. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr. Infect. Dis. J. 2008, 27, 762–764. [Google Scholar] [CrossRef] [PubMed]
- Blackwood, R.A.; Klein, K.C.; Micel, L.N.; Willers, M.L.; Mody, R.J.; Teitelbaum, D.H.; Cober, M.P. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr. Infect. Dis. J. 2011, 30, 1105–1107. [Google Scholar] [CrossRef] [PubMed]
- Shorr, A.F.; Wu, C.; Kothari, S. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. J. Antimicrob. Chemother. 2011, 66, 375–380. [Google Scholar] [CrossRef] [PubMed]
- Aikawa, N.; Kusachi, S.; Oda, S.; Takesue, Y.; Tanaka, H. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: Evaluation using the AKOTT algorithm. J. Infect. Chemother. 2009, 15, 219–227. [Google Scholar] [CrossRef] [PubMed]
- Cornely, O.A.; Pappas, P.G.; Young, J.A.; Maddison, P.; Ullmann, A.J. Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases. Expert Opin. Drug Saf. 2011, 10, 171–183. [Google Scholar] [CrossRef] [PubMed]
- Manzoni, P.; Benjamin, D.K.; Hope, W.; Rizzollo, S.; Del Sordo, P.; Stronati, M.; Jacqz-Aigrain, E.; Castagnola, E.; Farina, D. The management of Candida infections in preterm neonates and the role of micafungin. J. Matern. Fetal Neonatal. Med. 2011, 24, 24–27. [Google Scholar] [CrossRef] [PubMed]
- Queiroz-Telles, F.; Berezin, E.; Leverger, G.; Freire, A.; van der Vyver, A.; Chotpitayasunondh, T.; Konja, J.; Diekmann-Berndt, H.; Koblinger, S.; Groll, A.H.; et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial. Pediatr. Infect. Dis. J. 2008, 27, 820–826. [Google Scholar] [CrossRef] [PubMed]
- Privett, B.J.; Nutz, S.T.; Schoenfisch, M.H. Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation. Biofouling 2010, 26, 973–983. [Google Scholar] [CrossRef] [PubMed]
- Roe, D.; Karandikar, B.; Bonn-Savage, N.; Gibbins, B.; Roullet, J.B. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother. 2008, 61, 869–876. [Google Scholar] [CrossRef] [PubMed]
- Hanna, H.; Bahna, P.; Reitzel, R.; Dvorak, T.; Chaiban, G.; Hachem, R.; Raad, I. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob. Agents Chemother. 2006, 50, 3283–3288. [Google Scholar] [CrossRef] [PubMed]
- Carrasco, M.N.; Bueno, A.; de las Cuevas, C.; Jimenez, S.; Salinas, I.; Sartorius, A.; Recio, T.; Generelo, M.; Ruiz-Ocaña, F. Evaluation of a triple-lumen central venous heparin-coated catheter vs. a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med. 2004, 30, 633–638. [Google Scholar] [CrossRef] [PubMed]
- Walz, J.M.; Avelar, R.L.; Longtine, K.J.; Carter, K.L.; Mermel, L.A.; Heard, S.O. Anti-infective external coating of central venous catheters: A randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit. Care Med. 2010, 38, 2095–2102. [Google Scholar] [CrossRef] [PubMed]
- Menyhay, S.Z.; Maki, D.G. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: The promise of a novel antiseptic-barrier cap. Infect. Control Hosp. Epidemiol. 2006, 27, 23–27. [Google Scholar] [CrossRef] [PubMed]
- Menyhay, S.Z.; Maki, D.G. Preventing central venous catheter-associated bloodstream infections: Development of an antiseptic barrier cap for needleless connectors. Am. J. Infect. Control. 2008, 36, S174.e1–S174.e5. [Google Scholar] [PubMed]
- Leon, C.; Alvarez-Lerma, F.; Ruiz-Santana, S.; Gonzalez, V.; de la Torre, M.V.; Sierra, R.; León, M.; Rodrigo, J.J. Antiseptic chamber-containing hub reduces central venous catheter-related infection: A prospective, randomized study. Crit. Care Med. 2003, 31, 1318–1324. [Google Scholar] [CrossRef] [PubMed]
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bouza, E.; Guinea, J.; Guembe, M. The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia. Antibiotics 2015, 4, 1-17. https://doi.org/10.3390/antibiotics4010001
Bouza E, Guinea J, Guembe M. The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia. Antibiotics. 2015; 4(1):1-17. https://doi.org/10.3390/antibiotics4010001
Chicago/Turabian StyleBouza, Emilio, Jesús Guinea, and María Guembe. 2015. "The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia" Antibiotics 4, no. 1: 1-17. https://doi.org/10.3390/antibiotics4010001